171 related articles for article (PubMed ID: 31541894)
1. Dendrimer grafted albumin nanoparticles for the treatment of post cerebral stroke damages: A proof of concept study.
Pradhan D; Tambe V; Raval N; Gondalia P; Bhattacharya P; Kalia K; Tekade RK
Colloids Surf B Biointerfaces; 2019 Dec; 184():110488. PubMed ID: 31541894
[TBL] [Abstract][Full Text] [Related]
2. 'Dendrimer-Cationized-Albumin' encrusted polymeric nanoparticle improves BBB penetration and anticancer activity of doxorubicin.
Muniswamy VJ; Raval N; Gondaliya P; Tambe V; Kalia K; Tekade RK
Int J Pharm; 2019 Jan; 555():77-99. PubMed ID: 30448308
[TBL] [Abstract][Full Text] [Related]
3. PAMAM dendrimers: blood-brain barrier transport and neuronal uptake after focal brain ischemia.
Santos SD; Xavier M; Leite DM; Moreira DA; Custódio B; Torrado M; Castro R; Leiro V; Rodrigues J; Tomás H; Pêgo AP
J Control Release; 2018 Dec; 291():65-79. PubMed ID: 30308255
[TBL] [Abstract][Full Text] [Related]
4. Greatly improved neuroprotective efficiency of citicoline by stereotactic delivery in treatment of ischemic injury.
Xu F; Hongbin Han ; Yan J; Chen H; He Q; Xu W; Zhu N; Zhang H; Zhou F; Lee K
Drug Deliv; 2011; 18(7):461-7. PubMed ID: 21923252
[TBL] [Abstract][Full Text] [Related]
5. A Dual Targeting Drug Delivery System for Penetrating Blood-Brain Barrier and Selectively Delivering siRNA to Neurons for Alzheimer's Disease Treatment.
Zhang C; Gu Z; Shen L; Liu X; Lin H
Curr Pharm Biotechnol; 2017; 18(14):1124-1131. PubMed ID: 29484985
[TBL] [Abstract][Full Text] [Related]
6. Dendrimer-Based Drug Delivery Systems for Brain Targeting.
Zhu Y; Liu C; Pang Z
Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31783573
[TBL] [Abstract][Full Text] [Related]
7. Radioprotective effect of transferrin targeted citicoline liposomes.
Suresh Reddy J; Venkateswarlu V; Koning GA
J Drug Target; 2006 Jan; 14(1):13-9. PubMed ID: 16603447
[TBL] [Abstract][Full Text] [Related]
8. Generation dependent cancer targeting potential of poly(propyleneimine) dendrimer.
Kesharwani P; Tekade RK; Jain NK
Biomaterials; 2014 Jul; 35(21):5539-48. PubMed ID: 24731713
[TBL] [Abstract][Full Text] [Related]
9. Co-administration of a charge-conversional dendrimer enhances antitumor efficacy of conventional chemotherapy.
Cao J; Wang C; Guo L; Xiao Z; Liu K; Yan H
Eur J Pharm Biopharm; 2018 Jun; 127():371-377. PubMed ID: 29499301
[TBL] [Abstract][Full Text] [Related]
10. Nano carriers for drug transport across the blood-brain barrier.
Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
[TBL] [Abstract][Full Text] [Related]
11. Label-free CEST MRI Detection of Citicoline-Liposome Drug Delivery in Ischemic Stroke.
Liu H; Jablonska A; Li Y; Cao S; Liu D; Chen H; Van Zijl PC; Bulte JW; Janowski M; Walczak P; Liu G
Theranostics; 2016; 6(10):1588-600. PubMed ID: 27446492
[TBL] [Abstract][Full Text] [Related]
12. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas.
Li Y; He H; Jia X; Lu WL; Lou J; Wei Y
Biomaterials; 2012 May; 33(15):3899-908. PubMed ID: 22364698
[TBL] [Abstract][Full Text] [Related]
13. Mustard-inspired delivery shuttle for enhanced blood-brain barrier penetration and effective drug delivery in glioma therapy.
Wang N; Sun P; Lv M; Tong G; Jin X; Zhu X
Biomater Sci; 2017 May; 5(5):1041-1050. PubMed ID: 28378865
[TBL] [Abstract][Full Text] [Related]
14. Brain Targeting of Citicoline Sodium via Hyaluronic Acid-Decorated Novel Nano-Transbilosomes for Mitigation of Alzheimer's Disease in a Rat Model: Formulation, Optimization, in vitro and in vivo Assessment.
AbouElhassan KM; Sarhan HA; Hussein AK; Taye A; Ahmed YM; Safwat MA
Int J Nanomedicine; 2022; 17():6347-6376. PubMed ID: 36540376
[TBL] [Abstract][Full Text] [Related]
15. Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
Alibolandi M; Taghdisi SM; Ramezani P; Hosseini Shamili F; Farzad SA; Abnous K; Ramezani M
Int J Pharm; 2017 Mar; 519(1-2):352-364. PubMed ID: 28126548
[TBL] [Abstract][Full Text] [Related]
16. Natural Brain Penetration Enhancer-Modified Albumin Nanoparticles for Glioma Targeting Delivery.
Liang J; Gao C; Zhu Y; Ling C; Wang Q; Huang Y; Qin J; Wang J; Lu W; Wang J
ACS Appl Mater Interfaces; 2018 Sep; 10(36):30201-30213. PubMed ID: 30113810
[TBL] [Abstract][Full Text] [Related]
17. Surfactants, not size or zeta-potential influence blood-brain barrier passage of polymeric nanoparticles.
Voigt N; Henrich-Noack P; Kockentiedt S; Hintz W; Tomas J; Sabel BA
Eur J Pharm Biopharm; 2014 May; 87(1):19-29. PubMed ID: 24607790
[TBL] [Abstract][Full Text] [Related]
18. A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy.
Dong Y; Yu T; Ding L; Laurini E; Huang Y; Zhang M; Weng Y; Lin S; Chen P; Marson D; Jiang Y; Giorgio S; Pricl S; Liu X; Rocchi P; Peng L
J Am Chem Soc; 2018 Nov; 140(47):16264-16274. PubMed ID: 30346764
[TBL] [Abstract][Full Text] [Related]
19. Nootropic nanocomplex with enhanced blood-brain barrier permeability for treatment of traumatic brain injury-associated neurodegeneration.
Park J; Choi E; Shin S; Lim S; Kim D; Baek S; Lee KP; Lee JJ; Lee BH; Kim B; Jeong K; Baik JH; Kim YK; Kim S
J Control Release; 2018 Aug; 284():152-159. PubMed ID: 29913220
[TBL] [Abstract][Full Text] [Related]
20. Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier.
Teow HM; Zhou Z; Najlah M; Yusof SR; Abbott NJ; D'Emanuele A
Int J Pharm; 2013 Jan; 441(1-2):701-11. PubMed ID: 23089576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
